PW Medtech Group Limited (HKG:1358)

Market Cap	2.16B
Revenue (ttm)	818.25M
Net Income (ttm)	160.46M
Shares Out	1.49B
EPS (ttm)	0.10
PE Ratio	13.95
Forward PE	n/a
Dividend	0.10 (6.76%)
Ex-Dividend Date	Jul 3, 2025

Volume	1,199,000
Average Volume	3,192,485
Open	1.430
Previous Close	1.450
Day's Range	1.400 - 1.440
52-Week Range	0.910 - 1.480
Beta	0.51
RSI	68.22
Earnings Date	Aug 29, 2025

About PW Medtech Group

PW Medtech Group Limited, an investment holding company, operates as a medical device company in China, India, the Americas, Africa, and internationally. It operates through three segments: Infusion Set Business; Blood Purification Business; and Regenerative Medical Biomaterials Business. The company manufactures and sells infusion sets, such as non-PVC-based infusion sets, precision filter infusion sets, light resistant infusion sets, intravenous cannula products, and insulin needles and pens; hemodialysis and blood purification medical device...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1997
• Employees: 1,415
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1358

Financial Performance

In 2024, PW Medtech Group's revenue was 768.90 million, an increase of 13.90% compared to the previous year's 675.08 million. Earnings were 150.78 million, a decrease of -1.57%.

Financial numbers in CNY